Lin SH - Search Results

1

Current trials using bone-targeting agents in prostate cancer.

Tu SM, Lin SH. Tu SM, et al. Among authors: lin sh. Cancer J. 2008 Jan-Feb;14(1):35-9. doi: 10.1097/PPO.0b013e318161d32d. Cancer J. 2008. PMID: 18303481 Review.

2

Stem-cell origin of metastasis and heterogeneity in solid tumours.

Tu SM, Lin SH, Logothetis CJ. Tu SM, et al. Among authors: lin sh. Lancet Oncol. 2002 Aug;3(8):508-13. doi: 10.1016/s1470-2045(02)00820-3. Lancet Oncol. 2002. PMID: 12147437 Review.

3

Prostate carcinoma with testicular or penile metastases. Clinical, pathologic, and immunohistochemical features.

Tu SM, Reyes A, Maa A, Bhowmick D, Pisters LL, Pettaway CA, Lin SH, Troncoso P, Logothetis CJ. Tu SM, et al. Among authors: lin sh. Cancer. 2002 May 15;94(10):2610-7. doi: 10.1002/cncr.10546. Cancer. 2002. PMID: 12173328 Free article.

4

Antitumor activity of the 16-kDa prolactin fragment in prostate cancer.

Kim J, Luo W, Chen DT, Earley K, Tunstead J, Yu-Lee LY, Lin SH. Kim J, et al. Among authors: lin sh. Cancer Res. 2003 Jan 15;63(2):386-93. Cancer Res. 2003. PMID: 12543792

5

Re: A randomized, placebo-controlled trial of zoledronic acid in patients with hormone-refractory metastatic prostate carcinoma.

Tu SM, Lin SH, Logothetis C. Tu SM, et al. Among authors: lin sh. J Natl Cancer Inst. 2003 Aug 6;95(15):1174-5; author reply 1175. doi: 10.1093/jnci/djg020. J Natl Cancer Inst. 2003. PMID: 12902452 No abstract available.

6

Clinical aspects of bone metastases in prostate cancer.

Tu SM, Lin SH. Tu SM, et al. Among authors: lin sh. Cancer Treat Res. 2004;118:23-46. doi: 10.1007/978-1-4419-9129-4_2. Cancer Treat Res. 2004. PMID: 15043187 Review. No abstract available.

7

Up-regulation of MDA-BF-1, a secreted isoform of ErbB3, in metastatic prostate cancer cells and activated osteoblasts in bone marrow.

Vakar-Lopez F, Cheng CJ, Kim J, Shi GG, Troncoso P, Tu SM, Yu-Lee LY, Lin SH. Vakar-Lopez F, et al. Among authors: lin sh. J Pathol. 2004 Jun;203(2):688-95. doi: 10.1002/path.1568. J Pathol. 2004. PMID: 15141384

8

Osteoblasts in prostate cancer metastasis to bone.

Logothetis CJ, Lin SH. Logothetis CJ, et al. Among authors: lin sh. Nat Rev Cancer. 2005 Jan;5(1):21-8. doi: 10.1038/nrc1528. Nat Rev Cancer. 2005. PMID: 15630412 Review.

9

Therapy tolerance in selected patients with androgen-independent prostate cancer following strontium-89 combined with chemotherapy.

Tu SM, Kim J, Pagliaro LC, Vakar-Lopez F, Wong FC, Wen S, General R, Podoloff DA, Lin SH, Logothetis CJ. Tu SM, et al. Among authors: lin sh. J Clin Oncol. 2005 Nov 1;23(31):7904-10. doi: 10.1200/JCO.2005.01.2310. J Clin Oncol. 2005. PMID: 16258090

10

Pilot trial of bone-targeted therapy with zoledronate, thalidomide, and interferon-gamma for metastatic renal cell carcinoma.

Tannir N, Jonasch E, Pagliaro LC, Mathew P, Siefker-Radtke A, Rhines L, Lin P, Tibbs R, Do KA, Lin SH, Tu SM. Tannir N, et al. Among authors: lin sh, lin p. Cancer. 2006 Aug 1;107(3):497-505. doi: 10.1002/cncr.22038. Cancer. 2006. PMID: 16795067 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,735 results

Search Page

Filters